US pharma's political contributions in 2000

22 March 2001

US pharmaceutical industry political action committees spent $4.5million on congressional races in 2000, giving about $3.3 million to Republican candidates and $1.1 million to Democrats, say Federal Election Commission records reported in Drug Topics.

Glaxo Wellcome (now GlaxoSmithKline) gave a total of $604,759to 164 Republicans and 58 Democrats, donating the $10,000 legal maximum to 10 Senate candidates including Rick Lazio who ran in New York against Hillary Clinton. Other firms' donations were:

- Aventis Pasteur: $55,000 to Democrats and $53,000 to Republicans; - DuPont: $23,000, divided evenly between the two, - Eli Lilly: $414,850 to Republicans and $116,800 to Democrats; - Pfizer: $367,745 to Republicans and $91,725 to Democrats; - Bristol-Myers Squibb: $262,975 to Republicans and $68,003 to Democrats; - Merck: $229,697 to Republicans and $89,881 to Democrats; - Bayer: Republicans $187,000 and Democrats $58,500; and - the Pharmaceutical Research and Manufacturers of America: $81,482, with Republicans getting $65,982 and Democrats $15,500.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight